InsidersTradesSigma
Follow the 씨유메디칼 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 씨유메디칼 has logged 35 insider filings. Market capitalisation: €21.8bn. The latest transaction was disclosed on 13 July 2026 (Other). Among the most active insiders: 엑스큐어. The full history is free.
35
Insider Decl.
n/a
Thresholds
n/a
7 ops.
Buy Volume
n/a
15 ops.
Sell Volume
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 12,516 of 29,063 companies
55.5
score / 100
Value68
Quality43
FCF yld31%
Earn yld2.9%
EV/EBITDA9.9x
ROE·
Gross mgn59%
Net mgn1.7%
Debt/EBITDA5.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 July 2026
Declarations35 total
25 of 35 declarations
Acerca de 씨유메디칼
씨유메디칼 es una empresa centrada en el sector de la salud y farmacéutico, que cotiza en el mercado XKRX.